{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:40:13Z","timestamp":1759048813911,"version":"3.44.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,19]]},"abstract":"<jats:p>Cutaneous melanoma (CM) is the deadliest form of skin cancer, posing a significant threat to human health. In the ongoing efforts to develop effective treatments, identifying novel therapeutic targets is crucial. This research aimed to use Mendelian randomization and colocalization analysis to discover plasma proteins that could serve as new therapeutic targets for CM, while also assessing the potential adverse effects associated with these targets. The study harnessed plasma protein data from the UK Biobank Pharmaceutical Proteomics Project database, which contained genome-wide association data for 2940 proteins. These data were integrated with CM data from the Finnish database, involving 3194 patients and 314,193 controls. Proteome-wide analysis was then conducted to explore the associations between plasma proteins and CM risk. Through the proteome-wide analysis, 2 proteins, tyrosinase-related protein 1 and dipeptidase 1, were identified to have significant associations with CM risk. Notably, dipeptidase 1 exhibited an inverse relationship with CM risk, indicating its potential as a therapeutic target. However, the findings also raised concerns about its possible link to dementia. This comprehensive research approach successfully illuminated the causal relationships between specific plasma proteins and CM. It not only identified potential therapeutic targets but also emphasized the importance of understanding the broader implications of targeting these proteins, including potential adverse effects. The results lay the groundwork for further exploration of personalized treatment strategies for CM.<\/jats:p>","DOI":"10.1097\/md.0000000000044678","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:00:07Z","timestamp":1758574807000},"page":"e44678","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Proteome-wide Mendelian randomization and colocalization analysis identify therapeutic targets for cutaneous melanoma"],"prefix":"10.1097","volume":"104","author":[{"given":"Di","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Burns and Plastic Surgery, the second affiliated hospital of Naval Medical University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenrong","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Burns and Plastic Surgery, the second affiliated hospital of Naval Medical University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiefeng","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Burns and Plastic Surgery, the second affiliated hospital of Naval Medical University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohai","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Burns and Plastic Surgery, the second affiliated hospital of Naval Medical University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheyuan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Burns and Plastic Surgery, the second affiliated hospital of Naval Medical University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Jie","sequence":"additional","affiliation":[{"name":"Department of Burns and Plastic Surgery, the second affiliated hospital of Naval Medical University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lie","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Burns and Plastic Surgery, the second affiliated hospital of Naval Medical University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3753-7073","authenticated-orcid":false,"given":"Minjuan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Naval Medical University, Shanghai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250928","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","article-title":"Cutaneous melanoma.","volume":"402","author":"Long","year":"2023","journal-title":"Lancet"},{"key":"R2-20250928","first-page":"12","article-title":"Cancer statistics, 2024.","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R3-20250928","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/bjd\/ljae417","article-title":"Melanoma arising from pre-existing naevus in carriers of a germline CDKN2A pathogenic variant.","volume":"192","author":"Rauwerdink","year":"2025","journal-title":"Br J Dermatol"},{"key":"R4-20250928","first-page":"111","article-title":"The protective role of MC1R in chromosome stability and centromeric in tegrity in melanocytes.","volume":"7","author":"Li","year":"2021","journal-title":"Cell Death Discov"},{"key":"R5-20250928","doi-asserted-by":"crossref","first-page":"691032","DOI":"10.3389\/fimmu.2021.691032","article-title":"Association of NRAS mutation with clinical outcomes of anti-PD-1 monot herapy in advanced melanoma: a pooled analysis of four Asian clinical trials.","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Immunol"},{"key":"R6-20250928","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/CJI.0000000000000374","article-title":"PMEL as a prognostic biomarker and negatively associated with immune infiltration in skin cutaneous melanoma (SKCM).","volume":"44","author":"Zhang","year":"2021","journal-title":"J Immunother"},{"key":"R7-20250928","doi-asserted-by":"crossref","first-page":"31797","DOI":"10.18632\/oncotarget.25737","article-title":"Stromal CD38 regulates outgrowth of primary melanoma and generation of spontaneous metastasis.","volume":"9","author":"Ben Baruch","year":"2018","journal-title":"Oncotarget"},{"key":"R8-20250928","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1111\/jdv.14455","article-title":"Expression of monoacylglycerol lipase as a marker of tumour invasion and progression in malignant melanoma.","volume":"31","author":"Baba","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R9-20250928","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.7150\/jca.86735","article-title":"TNFSF10, an autophagy related gene, was a prognostic and immune infiltration marker in skin cutaneous melanoma.","volume":"14","author":"Xue","year":"2023","journal-title":"J Cancer"},{"key":"R10-20250928","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank.","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"R11-20250928","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jad.2024.02.083","article-title":"Gut microbiota and cognitive performance: a bidirectional two-sample Mendelian randomization.","volume":"353","author":"Wang","year":"2024","journal-title":"J Affect Disord"},{"key":"R12-20250928","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2337\/db23-0564","article-title":"Therapeutic targets for diabetic kidney disease: proteome-wide Mendelian randomization and colocalization analyses.","volume":"73","author":"Zhang","year":"2024","journal-title":"Diabetes"},{"key":"R13-20250928","doi-asserted-by":"crossref","first-page":"104494","DOI":"10.1016\/j.ebiom.2023.104494","article-title":"Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses.","volume":"89","author":"Chen","year":"2023","journal-title":"EBioMedicine"},{"key":"R14-20250928","doi-asserted-by":"crossref","first-page":"105033","DOI":"10.1016\/j.ebiom.2024.105033","article-title":"Phenome-wide Mendelian randomization analysis reveals multiple health comorbidities of coeliac disease.","volume":"101","author":"Yuan","year":"2024","journal-title":"EBioMedicine"},{"key":"R15-20250928","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMra052166","article-title":"Melanoma.","volume":"355","author":"Miller","year":"2006","journal-title":"N Engl J Med"},{"key":"R16-20250928","doi-asserted-by":"crossref","first-page":"14535","DOI":"10.3390\/ijms241914535","article-title":"The diagnosis and management of cutaneous metastases from melanoma.","volume":"24","author":"Di Raimondo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R17-20250928","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.gendis.2022.04.004","article-title":"Melanoma: molecular genetics, metastasis, targeted therapies, immunotherapies, and therapeutic resistance.","volume":"9","author":"Wagstaff","year":"2022","journal-title":"Genes Dis"},{"key":"R18-20250928","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.det.2022.07.007","article-title":"Targeted therapy and immunotherapy in melanoma.","volume":"41","author":"Lazaroff","year":"2023","journal-title":"Dermatol Clin"},{"key":"R19-20250928","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1470-2045(22)00687-8","article-title":"Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAF(V600) mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study.","volume":"24","author":"Ascierto","year":"2023","journal-title":"Lancet Oncol"},{"key":"R20-20250928","doi-asserted-by":"crossref","first-page":"113455","DOI":"10.1016\/j.ejca.2023.113455","article-title":"A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAF(V600) mutant advanced melanoma (INTERIM).","volume":"196","author":"Dayimu","year":"2024","journal-title":"Eur J Cancer"},{"key":"R21-20250928","doi-asserted-by":"crossref","first-page":"102290","DOI":"10.1016\/j.eclinm.2023.102290","article-title":"Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study.","volume":"65","author":"Bai","year":"2023","journal-title":"EClinicalMedicine"},{"key":"R22-20250928","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1006\/geno.1993.1126","article-title":"Physical and genetic mapping of the dipeptidase gene DPEP1 to 16q24.3.","volume":"15","author":"Austruy","year":"1993","journal-title":"Genomics"},{"key":"R23-20250928","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000133263","article-title":"Assignment of the human renal dipeptidase gene (DPEP1) to band q24 of chromosome 16.","volume":"59","author":"Nakagawa","year":"1992","journal-title":"Cytogenet Cell Genet"},{"key":"R24-20250928","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.canlet.2003.11.033","article-title":"Dipeptidase 1: a candidate tumor-specific molecular marker in colorectal carcinoma.","volume":"209","author":"McIver","year":"2004","journal-title":"Cancer Lett"},{"key":"R25-20250928","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/bjc.2013.363","article-title":"Dipeptidase 1 (DPEP1) is a marker for the transition from low-grade to high-grade intraepithelial neoplasia and an adverse prognostic factor in colorectal cancer.","volume":"109","author":"Eisenach","year":"2013","journal-title":"Br J Cancer"},{"key":"R26-20250928","first-page":"627","article-title":"A preliminary discussion on carnosine dipeptidase 1 as a potential novel biomarker for the diagnostic and prognostic evaluation of hepatocellular carcinoma.","volume":"31","author":"Li","year":"2023","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"R27-20250928","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.cell.2019.07.017","article-title":"Dipeptidase-1 is an adhesion receptor for neutrophil recruitment in lungs and liver.","volume":"178","author":"Choudhury","year":"2019","journal-title":"Cell"},{"key":"R28-20250928","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.molonc.2011.01.006","article-title":"Tyrosinase related protein 1 (TYRP1\/gp75) in human cutaneous melanoma.","volume":"5","author":"Ghanem","year":"2011","journal-title":"Mol Oncol"},{"key":"R29-20250928","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/pcmr.12951","article-title":"Human TYRP1: two functions for a single gene?","volume":"34","author":"Gautron","year":"2021","journal-title":"Pigment Cell Melanoma Res"},{"issue":"Pt 1","key":"R30-20250928","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1042\/bj3540131","article-title":"The 5,6-dihydroxyindole-2-carboxylic acid (DHICA) oxidase activity of human tyrosinase.","volume":"354","author":"Olivares","year":"2001","journal-title":"Biochem J"},{"key":"R31-20250928","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.1158\/1078-0432.CCR-16-1241","article-title":"An open-label, dose-escalation phase I study of anti-TYRP1 monoclonal antibody IMC-20D7S for patients with relapsed or refractory melanoma.","volume":"22","author":"Khalil","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R32-20250928","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.brainres.2009.01.058","article-title":"Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases.","volume":"1265","author":"Yin","year":"2009","journal-title":"Brain Res"},{"key":"R33-20250928","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s40257-022-00674-3","article-title":"A review of existing therapies for actinic keratosis: current status and future directions.","volume":"23","author":"Del Regno","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"R34-20250928","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2021.05.056","article-title":"Guidelines of care for the management of actinic keratosis: executive summary.","volume":"85","author":"Eisen","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"R35-20250928","doi-asserted-by":"crossref","first-page":"e076142","DOI":"10.1136\/bmjopen-2023-076142","article-title":"Multicentre, randomised, double-blind, placebo-controlled, proof of concept study of LSALT peptide as prevention of acute respiratory distress syndrome and acute kidney injury in patients infected with SARS-CoV-2 (COVID-19).","volume":"14","author":"Somayaji","year":"2024","journal-title":"BMJ Open"},{"key":"R36-20250928","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13045-021-01035-z","article-title":"Antibody-drug conjugates in solid tumors: a look into novel targets.","volume":"14","author":"Criscitiello","year":"2021","journal-title":"J Hematol Oncol"},{"key":"R37-20250928","doi-asserted-by":"crossref","first-page":"e70086","DOI":"10.1111\/cpr.70086","article-title":"PTRF confers melanoma-acquired drug resistance through the upregulation of EGFR.","author":"Wang","year":"2025","journal-title":"Cell Prolif"},{"key":"R38-20250928","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12943-024-02010-1","article-title":"RICTOR\/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF\/MEK inhibition.","volume":"23","author":"Ponzone","year":"2024","journal-title":"Mol Cancer"},{"key":"R39-20250928","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/s41467-024-45221-2","article-title":"CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes.","volume":"15","author":"Jilani","year":"2024","journal-title":"Nat Commun"},{"key":"R40-20250928","doi-asserted-by":"crossref","first-page":"123101","DOI":"10.1016\/j.biomaterials.2025.123101","article-title":"BRD4-targeted photodegradation nanoplatform for light activatable melanoma therapy.","volume":"317","author":"Lu","year":"2025","journal-title":"Biomaterials"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044678","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:02:13Z","timestamp":1759046533000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":40,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044678","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"assertion":[{"value":"2025-07-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}